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The Cell Cycle Regulatory Factor TAF1
Stimulates Ribosomal DNA Transcription
by Binding to the Activator UBF
further analysis (Figure 1A). The clone was sequenced,
and a nucleotide database search revealed that it is
identical to human TAF1 (previously known as TAFII250)
[12, 13]. TAF1 is the largest subunit of the TFIID complex
and is identical to a factor that has been implicated in
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The clone isolated from the yeast two-hybrid screenLos Angeles, California, 90033
encodes for the carboxy-terminal portion of TAF1, amino
acids 1096–1872. Additional yeast two-hybrid experi-
ments indicated that the region of UBF spanning HMG
Summary box 4 and the X-domain is sufficient for binding to TAF1
(Figure 1A). To obtain independent evidence for an inter-
Control of ribosome biogenesis is a potential mecha- action between TAF1 and UBF, we coinfected Sf9 cells
nism for the regulation of cell size during growth [1, with a baculovirus encoding for HA-tagged TAF1 and
2], and a key step in regulating ribosome production with baculoviruses expressing flag-tagged wild-type
is ribosomal RNA synthesis by RNA polymerase I (Pol UBF (F-UBF) or the mutants UBFdx, UBFdb34, UBF381N,
I) [3, 4]. In humans, Pol I transcription requires the and UBF491N. The results of these experiments indi-
upstream binding factor UBF and the selectivity factor cated that TAF1 coimmunoprecipitated with full-length
SL1 to assemble coordinately on the promoter [5–7]. UBF but not with a control protein (HCV-polymerase)
UBF is an HMG box-containing factor that binds to (Figure 1B). In contrast, a UBF mutant (UBFdx) missing
the rDNA promoter and activates Pol I transcription the X-domain failed to bind to TAF1, suggesting that
through its acidic carboxy-terminal tail [8, 9]. Using this region of UBF is required for the interaction. Further-
UBF (284–670) as bait in a yeast two-hybrid screen, more, a mutant form (UBFdb34) of UBF lacking the HMG
we have identified an interaction between UBF and boxes 3 and 4 bound poorly to TAF1. This finding was
TAF1, a factor involved in the transcription of cell cycle extended by the observation that the binding of
and growth regulatory genes [10]. Coimmunoprecipi- UBF381N and UBF491N to TAF1 is weak compared to
tation and protein-protein interaction assays con- that of full-length UBF (compare lane 6 with 7 and 8).
firmed that TAF1 binds to UBF. Confocal microscopy These results suggest that the region containing HMG
showed that TAF1 colocalizes with UBF in Hela cells, boxes 3 and 4 contributes to the stable association
and cell fractionation experiments provided further ev- between UBF and TAF1. A possible interpretation of
idence that a portion of TAF1 is localized in the nucleo- these data is that the TAF1 binding domain overlaps
lus, the organelle devoted to ribosomal DNA transcrip- with HMG box 4. Alternatively, HMG boxes 3 and 4 may
tion. Cotransfection and in vitro transcription assays provide the structural information necessary for efficient
showed that TAF1 stimulates Pol I transcription in a TAF1 binding.
dosage-dependent manner. Thus, TAF1 may be in- In a parallel set of experiments with TAF1 deletion
volved in the coordinate expression of Pol I- and Pol mutants, we determined that the region of TAF1 span-
II-transcribed genes required for protein biosynthesis ning amino acids 1054–1425 is required for UBF binding
and cell cycle progression. (See Figure S1 in the Supplementary Material available
with this article online). Taken together, these results
show that TAF1 interacts with UBF and confirm the find-
Results and Discussion ing of the yeast two-hybrid screen.
The RNA Pol I Transcription Factor UBF Interacts
with TAF1/CCG1 A Subpopulation of TAF1 Colocalizes and Is
The region of UBF from amino acid 284 to 670 was Associated with UBF in HeLa Cells
chosen as bait in a yeast two-hybrid system for screen- To further examine the link between TAF1 and UBF, we
ing a human testis cDNA library. This region of UBF, asked whether the two proteins colocalize in human
which includes HMG boxes 3 and 4 and the region from cells. HeLa cells were transfected with flag-TAF1, and
amino acid 492 to 670 (referred as the X-domain), is the localization of the transfected TAF1 and endogenous
required for optimal transcriptional activation [11]. UBF UBF was analyzed by confocal immunofluorescence mi-
(284–670) lacks a transactivation domain (amino acids croscopy. UBF is found in discrete foci within the nu-
670–765), and when fused to the Gal4DNA binding do- cleus, typical of the pattern of localization of this nucleo-
main, it is transcriptionally inactive in yeast. A cDNA lar protein (Figure 2A, panel a), whereas the pattern of
clone that interacted with UBF based on nutritional se- TAF1 labeling is more evenly distributed throughout the
lection and -galactosidase activity was selected for nucleus (Figure 2A, panel a″) [17]. Importantly, merged
images of both stainings indicate that a subpopulation
of TAF1 colocalizes with UBF (Figure 2A, panel a). An1Correspondence: comai@usc.edu
identical pattern of staining and colocalization between2 These authors contributed equally to this work.
3 Present address: Amgen Inc., Thousand Oaks, California 91320. UBF and a portion of TAF1 is also observed with cryo-
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Figure 1. TAF1 and UBF Interact with Each Other in the Yeast Two-Hybrid Assay and When Coexpressed in Insect Cells
(A) Gal4 fusion proteins used in the yeast two-hybrid assays are shown with the results of the -galactosidase assay and the growth in
deficient media. Numbers in parentheses indicate amino acid residues. Vectors and the library used in the assays were purchased from
Clontech Laboratories. pUA3-1 and pTD1-1 represent plasmids used as controls for positive interaction. PAS2-1 and pACT2 represent the
GAL4 DNA binding domain and activation domain vectors, respectively.
(B) Sf9 cells were coinfected with recombinant baculoviruses expressing HA-tagged TAF1 and flag-UBF, a series of flag-UBF mutants, or
flag-HCV polymerase (HCV Pol). Forty-eight hours after infection, cell extracts were prepared and incubated with anti-flag affinity resin (Kodak)
for immunoprecipitation of the bound proteins. Immunocomplexes were analyzed by SDS-PAGE, with subsequent immunoblotting and
detection with anti-TAF1 antibodies (Santa Cruz Biotechnology). An aliquot of each extract was also used in Western blots with antibodies
against TAF1 and the flag epitope for determination of protein expression. The amounts of extracts used in the immunoprecipitations were
normalized for the same content of flag-tagged protein.
(C) A schematic representation of UBF mutants used in the Sf9 coinfection experiments.
embedded thin sections of HeLa cells (Figure 2A, b–b). lished data). To provide additional evidence that a sub-
population of TAF1 is localized in the nucleolus, weThis pattern is specific for TAF1 because the staining
of a transfected HA-tagged GRIP1 construct, a member isolated nuclear (soluble  chromatin), nucleolar, and
nucleoplasmic fractions from Hela cells and determinedof the p160 family of coactivators, does not overlap
with UBF (our unpublished data). In addition, no specific the localization of TAF1, UBF, TAFI110, and Sp1 by im-
munoblot analysis. The results of these experimentspattern of fluorescence was observed when the primary
antibody was omitted from the protocol (our unpub- show that a portion of TAF1 is found in the nucleolus,
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tion, are found in the nucleolar fraction and are excluded
from the nucleoplasm (lane 3). Because equal amounts
of nucleoplasmic and nucleolar extracts were loaded
on the gel, the seeming lower abundance of TAF1 in the
nucleoplamic fraction is likely to be the result of TAF1
being less represented among the soluble nucleoplas-
mic proteins. Taken together, these findings indicate
that a subpopulation of TAF1 is localized in the nucleolus
and is likely to play a role that is distinct from its function
in the TFIID complex.
To further demonstrate that the nucleolar factor UBF
interacts with TAF1 in Hela cells, we examined whether
the two proteins can be coimmunoprecipitated from cell
extracts. For this purpose, nuclear extracts from HeLa
cells were incubated with antiserum against UBF or a
control preimmune serum, and the immunocomplexes
were then precipitated by incubation with protein
A-agarose. Proteins bound to the antibody-affinity bead
complex were resolved by SDS-PAGE and analyzed by
Western blotting with affinity-purified antibodies against
UBF, TAF1, and TAF4 (previously named TAFII130). The
results of the immunoprecipitation assays shown in Fig-
ure 2C indicate that TAF1, but not TAF4, coimmunopre-
cipitates with UBF from a nuclear extract. In addition,
neither UBF nor TAF1 were immunoprecipitated by the
control preimmune serum.
TAF1 Stimulates Pol I Transcription
in Transfections and Cell-Free
Transcription Assays
To determine whether TAF1 functions in Pol I transcrip-
tion, we transfected HeLa cells with a human rRNA pro-
moter construct (prHu3CAT) together with a plasmid
expressing either TAF1 or TAF4. Transfection of the pro-
moter construct produces a 123 nucleotide primer ex-
Figure 2. A Subpopulation of TAF1 Colocalizes with UBF tension fragment that corresponds to transcripts initi-
Confocal laser-scanning microscopy. Paraformaldehyde-fixed (a– ated at the Pol I transcription initiation site. In the
a) or cryodissected (b–b; 8 m sections) Hela cells were labeled
presence of TAF1, transcription from the human rRNAwith anti-UBF antibodies and TRITC-conjugated (a) or FITC-conju-
promoter is stimulated in a dosage-dependent fashiongated (b) anti-rabbit antibody, as well as with anti-flag antibodies
(Figure 3A). The stimulation of Pol I transcription is spe-and either FITC-conjugated (a″) or TRITC-conjugated (b″) anti-
mouse antibodies. Merged images are shown in panels a and b. cific for TAF1 because TAF4 failed to induce any signifi-
Yellow color indicates colocalization of both labels. Identical results cant increase in Pol I transcription.
were obtained with transfected HA-tagged TAF1. To further examine the functional relationship be-
(B) Nucleolar localization of TAF1. Forty-five or thirty (Sp1 immu-
tween TAF1 and Pol I transcription, we performed tran-noblot) g of total nuclear (soluble fraction  chromatin; lane 1),
scription assays with purified factors in a cell-free sys-nucleolar (lane 2), and nucleoplasmic (lane 3) extracts was resolved
tem. Recombinant TAF1 was purified from insect cellson SDS-PAGE, transferred to nitrocellulose, and analyzed with anti-
bodies against UBF, TAF1, TAFI110, and Sp1 (see Supplementary and was added to in vitro transcription reactions con-
Material for Experimental Procedures). taining a purified RNA polymerase I fraction, SL1, and
(C) UBF interacts with TAF1 in human cells. Nuclear extracts from recombinant UBF. The results of the transcription
approximately 1  108 cells were incubated with either anti-UBF
assays indicate that the addition of increasing amountsserum or a pre-immune serum. The resulting immunocomplexes
of TAF1 results in an incremental increase in Pol I tran-were precipitated with protein A-sepharose, resolved by SDS-PAGE,
scription (Figure 3B). The stimulation of transcriptionand analyzed with antibodies against TAF1 (top) TAF4 (middle), and
UBF (bottom). Input represents approximately 25 g of nuclear ex- depends on the presence of UBF and SL1 because TAF1
tract. did not activate transcription in the absence of either
one of these two factors (lanes 4 and 5). Moreover, the
addition of TFIID to the transcription reaction did not
have any effect on Pol I transcription (Figure 3C, lanesthe site of ribosomal DNA transcription (Figure 2B, lane
2). The presence of TAF1 in the nucleolar extract is not 5 and 6), indicating that the TAF1 present in the TBP-
TAFII complex is not capable of stimulating Pol I tran-due to cross-contamination during the preparation of
the extract because Sp1, an abundant nuclear factor, scription. To determine whether the interaction between
UBF and TAF1 is necessary for stimulating Pol I tran-is absent from this fraction (lane 2). As expected, UBF
and TAFI110, two factors involved in RNA pol I transcrip- scription, we added TAF1 to the transcription reaction
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in the presence of a UBF mutant (UBFdx) missing the
X-domain. UBFdx is competent to activate Pol I tran-
scription in an in vitro reconstituted transcription assay
[11], but it does not interact with TAF1 (Figure 1A). As
shown in Figure 3D, TAF1 failed to stimulate transcrip-
tion in the presence of UBFdx (lanes 1–3), suggesting
that the physical interaction between UBF and TAF1 is
required for the stimulation of Pol I transcription.
The finding that UBF, a Pol I-specific trans-acting fac-
tor, interacts with TAF1 is intriguing. TAF1 was originally
identified as a component of the TFIID complex, a Pol
II-specific factor incompetent of activating Pol I tran-
scription (see Figure 3C). Although TAFs were originally
thought to be exclusively subunits of the TFIID complex,
recent studies have revealed that some TAFs are com-
ponents of other cellular multiprotein complexes, such
as TFTC, SAGA, and PCAF, which, unlike TFIID, do not
contain TBP [18]. Although TAF1 is not a component of
these TBP-free complexes, a significant amount of TAF1
is found in a TBP-free form in human cells (our unpub-
lished data; [19]), and a recent study has shown that
Drosophila TAF1 (dmTAF1) is a component of the Poly-
comb Repressive Complex 1 (PRC1) [20]. Taken to-
gether, these results suggest that TAF1 is a regulatory
protein involved in several aspects of Pol I and II tran-
scription.
The involvement of TAF1 in the expression of genes
transcribed by different nuclear polymerases is reminis-
cent of the TATA binding protein (TBP), which was origi-
nally thought to be solely a Pol II factor but was later
also found to play an essential role in transcription by
Pol I and III [21]. More recently, TFIIH, a basal Pol II
transcription initiation factor, has been also implicated
in Pol I transcription [22].
The role of TAF1 in the transcription process is not well
understood, but is likely that the regulatory properties of
this factor are linked to its intrinsic enzymatic activity
(kinase, histone acetyltransferase (HAT), and ubiquitin
activating-conjugating activities) [10]. Gene chip hybrid-
ization and differential display experiments indicated
that TAF1 is required for the regulation of a subset of
Pol II-transcribed genes (16%–18%), most of which are
involved in G1-to-S progression and cell growth [23, 24].
Figure 3. Stimulation of RNA Polymerase I Transcription by TAF1
(A) The human ribosomal RNA gene promoter construct prHu3CAT
(3 g) was cotransfected with an empty pcDNA3 vector (bars 1 and
stained gels. An aliquot (3 l) of the preparation of recombinant2; 2 and 4 g, respectively), a plasmid expressing flag-TAF1 (bars
2 and 3; 2 g () and 4 g (), respectively), or a plasmid express- TAF1 used in the transcription reactions is shown in the inset (silver-
stained gel).ing HA-TAF4 (bars 4 and 5; 2 g () and 4 g (), respectively).
Ribonuclease protection assays (RPA) for -actin mRNA were used (C) Transcription reactions were performed in the presence of TAF1
(lane 3, 20 ng), UBF (lanes 1–3, 5, and 6), or increasing amounts offor normalizing the amount of RNA used in the primer extension
assays (inset, top panel). The primer extension data were quantified a TFIID fraction (lanes 5 and 6). Purified RNA polymerase I and SL1
were added to each reaction. The TFIID fraction used in the reactionswith a Phosphoimager (Molecular Dynamics), and relative activities
are shown as the mean  standard deviation. Data were obtained shown in lanes 5 and 6 contains approximately the same amount
(lane 5) or twice the amount (lane 6) of TAF1 used in lane 3, asfrom five independent experiments, except for transfections with
TAF4, which were performed twice. Expression of the transfected judged by Western blot analysis with TAF1 antibodies (not shown).
This TFIID fraction was active in Pol II transcription assays in vitroepitope-tagged proteins was determined by Western blot analysis
with flag (TAF1) and HA (TAF4) antibodies (inset, bottom panel). (not shown).
(D) Transcription reactions contained recombinant UBFdx (lanes(B) Increasing amounts of recombinant TAF1 (lanes 2 and 3, approxi-
mately 10 ng and 15 ng [0.8 l and 1.2 l], respectively; lanes 4 and 1–4 and 6; approximately 5 ng) and increasing amounts of recombi-
nant TAF1 (lanes 1–3; approximately 5 ng, 10 ng, and 15 ng, respec-5, 1.2 l each) were tested in reconstituted transcription assays in
the presence of a purified RNA polymerase I fraction (lanes 1–5), tively; lanes 4 and 5, 10 ng each). Recombinant UBF was used in
the reaction shown in lane 7. Purified SL1 was omitted from thepurified SL1 (lanes 1–4), and recombinant UBF (approximately 5
ng; lanes 1–3 and 5). Transcription reactions were carried out as reaction shown in lane 4. Asterisks indicate the background level
of activity. All the transcription experiments have been repeatedpreviously described [7, 9]. The amount of each recombinant pro-
tein used in the transcription assays was estimated from silver- several times with identical results.
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